Retropubic Hydrodissection and Trocar-induced Bladder Perforation During Retropubic Midurethral Slings
Part of paid clinical trials in Worcester, Massachusetts.
- Sponsor
- University of Massachusetts, Worcester
- Study ID
- NCT07208682
- Status
- Recruiting
Conditions
- Bladder Perforation
- Retropubic Hydrodissection
- Retropubic Midurethral Sling
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- retropubic hydrodissection — PROCEDUREsubjects would receive retropubic hydrodissection prior to passage of the trocars. A total of 60cc of sterile injectable saline would be injected in the retropubic space with a 20g spinal needle along the anticipated path of the trocar.
Study Details
Retropubic midurethral slings are a common and effective treatment for stress urine incontinence. The trocar that is attached to the mesh material can hit the bladder which is called a perforation. While there are no known long-term adverse outcomes from trocar-induced bladder perforations, it can prolong operative time and bleeding. At academic institutions, it has been reported that trocar-induced perforations occurs in the range of 14-34% of the time. This study is a randomized controlled trial to see if an intervention can decrease trocar-induced bladder perforation rates. The primary outcome of this study is to measure trocar-induced bladder perforations in subjects undergoing a retropubic midurethral sling. Subjects would be randomized to either receive the hydrodissection in a standardized manner or to not receive it. Secondary outcomes include bothersome urinary symptoms, pain, estimated blood loss during surgery, and voiding trial results
Key Dates
- Start date
- Apr 3, 2025
- Status verified
- Sep 2025
- Primary completion
- Apr 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 300 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: Retropubic hydrodissectionsubjects would receive a total of 60cc sterile injectable saline in the retropubic space using a 20g spinal needle placed in the anticipated path of the trocars
- No Intervention: No retropubic hydrodissectionthis group would not receive retropubic hydrodissection
Primary Outcome Measure
trocar-induced bladder perforation [ Time Frame: during the surgery ]
Central Contacts
- Emily Wu, MD508-334-9840
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | 01605 |